Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
pancreatic cancer
Biotech
Survival mushrooms in Golden Biotech’s pancreatic cancer trial
The biotech linked first-line use of its mushroom-derived molecule to median overall survival of 14.1 months in metastatic pancreatic cancer.
Nick Paul Taylor
Jan 18, 2024 9:47am
Heart drug sheds light on potential pancreatic cancer therapy
Jan 2, 2024 6:30am
Merus' NRG1+ drug responses edge up in tough pancreatic cancer
Oct 23, 2023 7:30am
KRAS inhibitor, immunotherapy halts pancreatic cancer in mice
Aug 29, 2023 9:56am
Novartis axes obesity drug as high-risk, high-reward bet fails
Jul 18, 2023 5:47am
Researchers find 'highly synergistic' pancreatic cancer combo
Jun 30, 2023 12:57pm